KR890001809B1 - Process for preparing 2,3-cis 1,2,3,4-tetrahydro-5-(2-hydroxy-3-tert-butylamino)propoxy-2,3-napththalenediol - Google Patents

Process for preparing 2,3-cis 1,2,3,4-tetrahydro-5-(2-hydroxy-3-tert-butylamino)propoxy-2,3-napththalenediol Download PDF

Info

Publication number
KR890001809B1
KR890001809B1 KR8204038A KR820004038A KR890001809B1 KR 890001809 B1 KR890001809 B1 KR 890001809B1 KR 8204038 A KR8204038 A KR 8204038A KR 820004038 A KR820004038 A KR 820004038A KR 890001809 B1 KR890001809 B1 KR 890001809B1
Authority
KR
South Korea
Prior art keywords
lower alkyl
tert
tetrahydro
heterocyclic
epichlorohydrin
Prior art date
Application number
KR8204038A
Other languages
Korean (ko)
Other versions
KR840001567A (en
Inventor
죠오지 앤더슨 니일
Original Assignee
죠오지 제이.코에서
이이.아르.스퀴부 앤드 산즈 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 죠오지 제이.코에서, 이이.아르.스퀴부 앤드 산즈 인코포레이티드 filed Critical 죠오지 제이.코에서
Priority to KR8204038A priority Critical patent/KR890001809B1/en
Publication of KR840001567A publication Critical patent/KR840001567A/en
Application granted granted Critical
Publication of KR890001809B1 publication Critical patent/KR890001809B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Title cpd. (I) was treated by epichlorohydrine with piperidine as a catalyst, and the powder state of the product obtained was reacted with tert-buthylamine to produce amino alcohol (III). 2,3-cis- 1,2,3,4-tetrahydro-5-[(2-hydroxy-3-tert-buthylamino)propoxy -2,3- naphthalenediol was prepared by hydrolysis of amino alcohol (III). The title cpd. is useful for treating heart attack and high blood pressure.

Description

2,3-시스-1,2,3,4-테트라히드로-5-[(2-히드록시-3-tert-부틸아미노)-프로폭시]-2,3-나프탈렌디올의 제조방법Method for preparing 2,3-cis-1,2,3,4-tetrahydro-5-[(2-hydroxy-3-tert-butylamino) -propoxy] -2,3-naphthalenediol

본 발명은 협심증 및 고혈압 치료에 유용한 비선택성 베타-아드레날린 수용체 차단제인 나돌롤(Nadolol), 즉 2,3-시스-1,2,3,4-테트라히드로-5-[(2-히드록시-3-tert-부틸아미노)프로폭시]-2,3-나프탈렌디올의 제조방법에 관한 것이다. 나돌롤 및 그의 제조방법은 호크(Hauck)등의 미합중국 특허 제3,935,267호에 기재되어 있다. 특히, 실시예 34에는 5,8-디히드로-1-나프톨을 반응시켜서 시스-5,6,7,8-테트라히드로-1,6,7-나프탈렌트리올을 얻고, 이어서 이 트리올을 에피클로로히드린으로 처리하여 2,3-시스-1,2,3,4-테트라히드로-5-[2,3-(에폭시)프로폭시]-2,3-타프탈렌디올을 얻고, 이 중간체를 tert-부틸아민과 반응시켜서 목적 생성물, 즉 나돌롤을 제조하는 방법이 기재되어 있다.The present invention relates to nadolol, a nonselective beta-adrenergic receptor blocker useful for the treatment of angina and hypertension, namely 2,3-cis-1,2,3,4-tetrahydro-5-[(2-hydroxy- 3-tert-butylamino) propoxy] -2,3-naphthalenediol. Nadolol and methods for its preparation are described in US Pat. No. 3,935,267 to Hawk et al. In particular, in Example 34, 5,8-dihydro-1-naphthol was reacted to give cis-5,6,7,8-tetrahydro-1,6,7-naphthalenetriol, which was then epiolated. Treatment with chlorohydrin yields 2,3-cis-1,2,3,4-tetrahydro-5- [2,3- (epoxy) propoxy] -2,3-taphthalenediol, which intermediate is A method for producing the desired product, i.e. nadolol, by reaction with tert-butylamine is described.

호크등의 동독 특허 제129,322호에는, 시스-5,6,7,8-테트라히드로-1,6,7-나프탈렌트리올을 아세탈 또는 케탈과 반응시켜 하기 일반식,East German Patent No. 129,322 to Hawk et al. Discloses cis-5,6,7,8-tetrahydro-1,6,7-naphthalenetriol reacted with acetal or ketal to the following general formula,

Figure kpo00001
Figure kpo00001

으로 나타내는 화합물을 얻고, 이 화합물을 유기 용매 존재하에 에피클로로히드린과 반응시켜 하기 일반식,To obtain a compound represented by the above reaction, and reacting the compound with epichlorohydrin in the presence of an organic solvent,

Figure kpo00002
Figure kpo00002

으로 나타낸는 에폴시드를 얻고, 이 에폭시드를 메탄올 존재하에 tert-부틸아민으로 처리하여 하기 일반식,The epoxide is obtained, and this epoxide is treated with tert-butylamine in the presence of methanol to give the following general formula,

Figure kpo00003
Figure kpo00003

으로 나타내는 화합물을 얻고, 이어서 이 화합물을 가수 분해시켜서 나돌롤을 제조하는 방법이 기재되어 있다.The method of obtaining a compound shown by following, and then hydrolyzing this compound to manufacture a nadolol is described.

본 발명은 상기 동독 특허에 기재되어 있는 나돌롤의 제조방법을 개량한 것이다.The present invention is an improvement of the method for producing nadolol described in the East German patent.

본 발명에 의하면, 하기 일반식(I),According to this invention, the following general formula (I),

Figure kpo00004
Figure kpo00004

으로 표시되는 시클릭 유도체는 보다 적은 당량의 에피클로로히드린의 요구되는 방법으로, 하기 일반식(III),The cyclic derivative represented by the following method is a required method of the lower equivalent of epichlorohydrin, the following general formula (III),

Figure kpo00005
Figure kpo00005

으로 표시되는 아미노 알코올로 전환된다.It is converted to amino alcohol represented by.

또한, 상기 일반식(I)의 시클릭 중간체와 에피클로로 히드린과의 반응은 유기 용매 없이 진행되며, 생성된 조(粗) 혼합물을 추출시킬 필요 없이 물 존재하에 tert-부틸아민과 반응시키면 상기 일반식(III)의 목적 아미노알코올 중간체를 얻을 수 있다. 이어서, 일반식(III)의 아미노 알코올을 공지된 방법으로 가수 분해시킴으로써 나돌롤이 얻어진다.In addition, the reaction between the cyclic intermediate of Formula (I) and epichlorohydrin proceeds without an organic solvent, and when reacted with tert-butylamine in water without extracting the resultant crude mixture, The desired aminoalcohol intermediate of formula (III) can be obtained. Next, nadolol is obtained by hydrolyzing the amino alcohol of the general formula (III) by a known method.

따라서, 본 발명의 방법은 종래의 방법에 비하여, 보다 소량의 에피클로로히드린을 요하며, 유기 용매가 필요없고, 추출과 조작의 횟수가 더욱 줄어들게 되므로 경제적인 장점이 있다.Therefore, the method of the present invention has an economical advantage compared to the conventional method because it requires a smaller amount of epichlorohydrin, requires no organic solvent, and further reduces the number of extraction and manipulation.

본 발명의 개량된 방법에 따르면, 일반식(I)의 시클릭 유도체가 유기 용매 부재하에 6당량 이하의 에피클로로히드린과 반응을 일으킨다. 이 방법에서는 촉매량의 피페리딘이 사용된다. 이 반응에 의하여, 하기 일반식(IIa)의 화합물과 일반식(IIb)의 화합물의 혼합물 생성된다.According to an improved process of the invention, the cyclic derivatives of formula (I) react with up to 6 equivalents of epichlorohydrin in the absence of an organic solvent. In this method, a catalytic amount of piperidine is used. By this reaction, a mixture of a compound of the following general formula (IIa) and a compound of the general formula (IIb) is produced.

Figure kpo00006
Figure kpo00006

Figure kpo00007
Figure kpo00007

이어서, 이 혼합물을 추출시키는 일이 없이 물을 용매로 사용하여 tert-부틸아민 5 당량과 반응시켜서 일반식(III)의 아미노 알코올을 얻는다. 이 아미노 알코올을 가수분해시키면 나돌롤이 생성된다.Subsequently, without extracting this mixture, water is used as a solvent and reacted with 5 equivalents of tert-butylamine to obtain an amino alcohol of the general formula (III). Hydrolysis of this amino alcohol produces nadolol.

호크 등의 동독 특허 제192,322호에 기재된 바와같이, 일반식(I)의 시클릭 유도체는, 시스-5,6,7,8-테트라히드로-1,6,7-나프탈렌트리올을 알데히드 또는 일반식,

Figure kpo00008
로 표시되는 케톤, 또는 아세탈, 케탈 또는 이들의 엔올 에테르 유도체와 반응시킴으로써 얻어진다. 이 반응은 카르보닐(또는 카르보닐 유도체) 반응물 중의 트리올 현탁액 또는 용액을 산 촉매, 예를들면, 과염소산, p-톨루엔술폰산, 염산 등으로 처리 후 중화시키고, 이어서 생성된 시클릭 아세탈 또는 케탈 유도체 [일반식 (I)]를 회수함으로써 진행시키는 것이 좋다. 사용한 카르보닐(또는 카르보닐 유도체) 반응물이 고체일 경우에는 유기 용매도 역시 사용된다. 이 반응은 약20°-120℃, 바람직하게는 20°-50℃에서 수행되며, 약 0.5-24시간이 소요된다.As described in East German Patent No. 192,322 to Hawk et al., Cyclic derivatives of general formula (I) are cis-5,6,7,8-tetrahydro-1,6,7-naphthalenetriol as aldehyde or general expression,
Figure kpo00008
It is obtained by reacting with a ketone or acetal, ketal or an enol ether derivative thereof. This reaction neutralizes the triol suspension or solution in the carbonyl (or carbonyl derivative) reactant after treatment with an acid catalyst such as perchloric acid, p-toluenesulfonic acid, hydrochloric acid, and the like, followed by the resulting cyclic acetal or ketal derivatives. It is good to advance by recovering [General Formula (I)]. If the carbonyl (or carbonyl derivative) reactant used is a solid, an organic solvent is also used. This reaction is carried out at about 20 ° -120 ° C., preferably 20 ° -50 ° C., and takes about 0.5-24 hours.

상기 일반식에서, R1은 수소, 저급 알킬, 할로 저급 알킬, 카르복시 저급 알킬(또는 이들의 에스테르), 모노시클릭 시클로알킬, 모노카르보시클릭 아릴, 모노카르보시클릭 아릴 저급 알킬, 모노시클릭 헤테로시클릭 또는 모노시클릭 헤테로시클릭 저급 알킬기이고, R2는 저급 알킬, 할로 저급 알킬, 카르복시 저급 알킬(또는 이들의 에스테르), 모노시클릭 시클로알킬, 모노카르보시클릭 아릴, 모노시클릭 아릴 저급 알킬, 모노시클릭 헤테로시클릭 또는 모노시클릭 헤테로시클릭 저급 알킬기이다.Wherein R 1 is hydrogen, lower alkyl, halo lower alkyl, carboxy lower alkyl (or ester thereof), monocyclic cycloalkyl, monocarbocyclic aryl, monocarbocyclic aryl lower alkyl, monocyclic hetero A cyclic or monocyclic heterocyclic lower alkyl group, R 2 is lower alkyl, halo lower alkyl, carboxy lower alkyl (or ester thereof), monocyclic cycloalkyl, monocarbocyclic aryl, monocyclic aryl lower Alkyl, monocyclic heterocyclic or monocyclic heterocyclic lower alkyl groups.

"저급 알킬기"는 탄소 원자 수가 최대 7개인 직쇄 또는 분지쇄 탄화수소기, 예를 들면 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, t-부틸기등인데, 다만 R1과 R2중 어느 하나만이 분지쇄 탄화수소기가 될수 있다."Lower alkyl group" is a straight or branched chain hydrocarbon group having up to 7 carbon atoms, such as methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, t-butyl group, etc., provided that R 1 and Only one of R 2 can be a branched chain hydrocarbon group.

"할로"는 불소, 염소, 브롬 및 요오드를 의미하는데, 이 중에서 염소와 브롬이 좋다."Halo" means fluorine, chlorine, bromine and iodine, of which chlorine and bromine are preferred.

R1과 R2는 모두 메틸기인 것이 좋다.It is preferable that both R 1 and R 2 are methyl groups.

본 발명을 아래 실시예에 따라 본 발명을 더욱 구체적으로 설명하겠다.The present invention will be described in more detail with reference to the following examples.

[실시예]EXAMPLE

2,3-시스-1,2,3,4-테트라히드로-5-[(2-히드록시-3-tert-부틸아미노)프로폭시]-2,3-나프탈렌디올2,3-cis-1,2,3,4-tetrahydro-5-[(2-hydroxy-3-tert-butylamino) propoxy] -2,3-naphthalenediol

a) 5-(2,3-에폭시프로폭시)-3a,4,9,9a-테트라히드로-2,2-디메틸-2H-나프토[2,3-d]-1,3-디옥솔 및 5-(3-클로로-2-히드록시프로폭시)-3a,4,9,9a-테트라히드로-2,2-디메틸-2H-나프토[2,3-d]-1,3-디옥솔의 혼합물a) 5- (2,3-epoxypropoxy) -3a, 4,9,9a-tetrahydro-2,2-dimethyl-2H-naphtho [2,3-d] -1,3-dioxol and 5- (3-chloro-2-hydroxypropoxy) -3a, 4,9,9a-tetrahydro-2,2-dimethyl-2H-naphtho [2,3-d] -1,3-diosol Mixture of

5-히드록시-3a,9a-시스-3a,4,9,9a-테트라히드로-2,2-디메틸-2H-나프토[2,3-d]-1,3-디옥솔 121.15g(0.55몰)을 에피클로로히드린 259ml(3.3몰) 중에서 피페리딘 13방울 (약 0.005)로 처리하였다. 이 현탁액을 환류 온도(116℃)까지 신속히 가열시키고, 생성된 갈색 용액을 이 환류 온도에서 4시간 동안 유지하였다. 휘발 성분을 회전증발시켜 제거하고, 남은 잔류물 약 160ml를 감압하에서 물200ml로 2회 공비혼합시켜, 점조성 잔류물 약 200ml를 얻었다. 이 잔류물은 5-(2,3-에폭시프로폭시)-3a,4,9,9a-테트라히드로-2,2-디메틸-2H-나프토[2,3-d]-1,3-디옥솔과 5-(3-클로로-2-히드록시프로폭시)-3a-4,9,9a-테트라히드로-2,2-디메틸-2H-나프토[2,3-d]-1,3-디옥솔의 혼합물로 구성되어 있다는 것을 확인하였다.5-hydroxy-3a, 9a-cis-3a, 4,9,9a-tetrahydro-2,2-dimethyl-2H-naphtho [2,3-d] -1,3-diosol 121.15 g (0.55) Mole) was treated with 13 drops of piperidine (about 0.005) in 259 ml (3.3 moles) of epichlorohydrin. This suspension was quickly heated to reflux (116 ° C.) and the resulting brown solution was maintained at this reflux for 4 hours. The volatile components were removed by rotary evaporation, and about 160 ml of the remaining residue was azeotrope mixed twice with 200 ml of water under reduced pressure to obtain about 200 ml of viscous residue. This residue is taken from 5- (2,3-epoxypropoxy) -3a, 4,9,9a-tetrahydro-2,2-dimethyl-2H-naphtho [2,3-d] -1,3-di Oxol and 5- (3-chloro-2-hydroxypropoxy) -3a-4,9,9a-tetrahydro-2,2-dimethyl-2H-naphtho [2,3-d] -1,3- It was confirmed that it consisted of a mixture of dioxol.

b) 5-[(2-히드록시-3-tert-부틸아미노)프로폭시]-3a,4,9,9a-테트라히드로-2,2-디메틸-2H-나프토[2,3-d]-디옥솔b) 5-[(2-hydroxy-3-tert-butylamino) propoxy] -3a, 4,9,9a-tetrahydro-2,2-dimethyl-2H-naphtho [2,3-d] Dioxol

상기 공정 a)에서 얻은 잔류물을 tert-부틸아민 289ml(2.75몰)에 용해시키고, 이 용액에 물 85ml를 첨가하였다. 생성된 담갈색의 균질 용액을 2시간 동안(72℃)환류시킨 다음 약간 냉각시켰다. 감압하에서 물을 제거하여 점조성 잔류물인 5-[(2-히드록시-3-tert-부틸아미노)프로폭시]-3a,4,9,9a-테트라히드로-2,2-디메틸-2H-나프토[2,3-d]-1,3-디옥솔 약 350ml를 얻었다.The residue obtained in step a) was dissolved in 289 ml (2.75 moles) of tert-butylamine and 85 ml of water was added to this solution. The resulting pale brown homogeneous solution was refluxed for 2 hours (72 ° C.) and then cooled slightly. Water was removed under reduced pressure to yield a viscous residue, 5-[(2-hydroxy-3-tert-butylamino) propoxy] -3a, 4,9,9a-tetrahydro-2,2-dimethyl-2H-naph Approximately 350 ml of earth [2,3-d] -1,3-dioxol were obtained.

c) 2,3-시스-1,2,3,4-테트라히드로-5-[(2-히드록시-3-tert-부틸아미노)프로폭시]-2,3-나프탈렌디올c) 2,3-cis-1,2,3,4-tetrahydro-5-[(2-hydroxy-3-tert-butylamino) propoxy] -2,3-naphthalenediol

상기 공정 b)에서 얻은 잔류물을 염화메틸렌 500ml와 물 100ml중에 용해시키고, 염화메틸을 더 첨가하여 수층을 세척하였다. 유기 추출물을 한데 모은 다음에 물 800ml를 첨가하고, 이어서 진한 HCI 85ml를 첨가하였다. 이 혼합물에 진한 HCI을 더 첨가하여 pH를 0.7내지 0.9로 조정하였다. 이 혼합물을 30°-35℃에서 2.5시간동안 교반하고 이어서 냉각시켰다. 수층을 염화메틸렌 150ml로 세척하고, 여기에 염화메틸렌을 더 첨가한 다음, 이어서 10N 수산화나트륨 100ml를 첨가하였다. 수층은 염화메틸렌으로 2회 추출하고, 유기 추출물은 한데 모아 30°-35℃에서 가온하였다. 이 현탁액을 여과하고, 여액을 감압하에 농축시켜 점조성 잔류물 약 260ml를 얻었다. 이 잔류물을 아세톤 1600ml에 붓고, 0°-5℃에서 4시간 동안 냉각시킨후, 생성물을 여과하고 냉(冷) 아세톤 270ml로 세척하였다. 침전을 50℃에서 건조시켜 2,3-시스-1,2,3,4-테트라히드로-5-[(2-히드록시-3-tert-부틸아미노)프로폭시]-2,3-나프탈렌디올 133.28g을 얻었다.The residue obtained in step b) was dissolved in 500 ml of methylene chloride and 100 ml of water, and the aqueous layer was washed with the addition of methyl chloride. The combined organic extracts were added followed by 800 ml of water followed by 85 ml of concentrated HCI. To the mixture was further added concentrated HCI to adjust the pH to 0.7-0.9. The mixture was stirred at 30 ° -35 ° C. for 2.5 hours and then cooled. The aqueous layer was washed with 150 ml of methylene chloride, to which further methylene chloride was added, followed by 100 ml of 10N sodium hydroxide. The aqueous layer was extracted twice with methylene chloride, and the organic extracts were collected and warmed at 30 ° -35 ° C. This suspension was filtered and the filtrate was concentrated under reduced pressure to give about 260 ml of viscous residue. The residue was poured into 1600 ml of acetone and cooled at 0 ° -5 ° C. for 4 hours, after which the product was filtered and washed with 270 ml of cold acetone. The precipitate was dried at 50 ° C. to give 2,3-cis-1,2,3,4-tetrahydro-5-[(2-hydroxy-3-tert-butylamino) propoxy] -2,3-naphthalenediol 133.28 g was obtained.

Claims (6)

(a)하기 일반식(I)의 시클릭 유도체를 촉매량의 피페리딘 존재하에 에피클로로히드린으로 처리하는 공정, (b) 상기 공정 (a)에서 얻은 조(粗) 반응 생성물을 tert-부틸아민으로 처리하여 하기 일반식(III)의 아미노 알코올의 얻는 공정 및 (c) 이어서, 상기 공정(b)의 아미노 알코올 생성물을 가수 분해기키는 공정으로 이루어진 것을 특징으로 하는 2,3-시스-1,2,3,4-테트라히드로-5-[(2-히드록시-3-tert-부틸아미노)프로폭시]-2,3-나프탈렌디올의 제조방법(a) treating the cyclic derivative of formula (I) with epichlorohydrin in the presence of a catalytic amount of piperidine, (b) tert-butyl as a crude reaction product obtained in step (a) 2,3-cis-1 comprising a step of obtaining an amino alcohol of the following general formula (III) by treating with an amine, and then (c) hydrolyzing the amino alcohol product of the step (b). Method for preparing 2,3,4-tetrahydro-5-[(2-hydroxy-3-tert-butylamino) propoxy] -2,3-naphthalenediol
Figure kpo00009
Figure kpo00009
위 각 식에 있어서, R1은 수소, 저급 알킬, 할로 저급 알킬, 카르복시 저급 알킬, 모노시클릭 시클로알킬, 모노카르보시클릭 아릴, 모노카르보시클릭 아릴 저급 알킬, 모노시클릭 헤테로시클릭 또는 모노시클릭 헤테로시클릭 저급 알킬기이고, R2는 저급 알킬, 할로 알킬, 카르복시 저급 알킬, 모노시클릭 시클로알킬, 모노카르보시클릭 아릴, 모노 카르보시클릭 아릴 저급 알킬, 모노시클릭 헤테로시클릭 또는 모노시클릭 헤테로시클릭 저급 알킬이다.In each formula, R 1 is hydrogen, lower alkyl, halo lower alkyl, carboxy lower alkyl, monocyclic cycloalkyl, monocarbocyclic aryl, monocarbocyclic aryl lower alkyl, monocyclic heterocyclic or mono Cyclic heterocyclic lower alkyl group, R 2 is lower alkyl, halo alkyl, carboxy lower alkyl, monocyclic cycloalkyl, monocarbocyclic aryl, mono carbocyclic aryl lower alkyl, monocyclic heterocyclic or mono Cyclic heterocyclic lower alkyl.
제1항에 있어서, R1및 R2가 모두 메틸기인 방법.The method of claim 1, wherein R 1 and R 2 are both methyl groups. 제1항에 있어서 공정 (a)에서는 6당량 이하의 에피클로로히드린을 사용하고 반응을 유기 용매 부재하에 진행하며, 공정 (b)에서는 5당량의 tert-부틸아민을 사용하고 반응을 유기 용매 부재하에서 진행하는 방법.The process according to claim 1, wherein in step (a) no more than 6 equivalents of epichlorohydrin are used and the reaction is carried out in the absence of an organic solvent, in step (b), 5 equivalents of tert-butylamine are used and the reaction is carried out in the absence of an organic solvent. How to proceed under. (a) 하기 일반식(II)의 시클릭 유도체를 촉매량의 피페리딘 존재하에 에피클로로히드린으로 처리하는 공정 및 (b) 상기 공정 (a)에서 얻은 조반응 생성물은 tert-부틸아민으로 처리하는 공정으로 이루어진 것을 특징으로하는 하기 일반식(III)의 아미노 알코올의 제조방법.(a) treating the cyclic derivative of formula (II) with epichlorohydrin in the presence of a catalytic amount of piperidine and (b) the crude reaction product obtained in step (a) is treated with tert-butylamine A process for producing the amino alcohol of the general formula (III)
Figure kpo00010
Figure kpo00010
위 각 식에 있어서, R1은 수소, 저급 알킬, 할로 저급 알킬, 카르복시 저급 알킬, 모노시클릭 시클로알킬, 모노카르보시클릭 아릴, 모노카르보시클릭 아릴 저급 알킬, 모노시클릭 헤테로시클릭 또는 모노시클릭 헤테로시클릭 저급 알킬기이고, R2는 저급 알킬, 할로 알킬, 카르복시 저급 알킬, 모노시클릭 시클로알킬, 모노카르보시클릭 아릴, 모노 카르보시클릭 아릴 저급 알킬, 모노시클릭 헤테로시클릭 또는 모노시클릭 헤테로시클릭 저급 알킬기이다.In each formula, R 1 is hydrogen, lower alkyl, halo lower alkyl, carboxy lower alkyl, monocyclic cycloalkyl, monocarbocyclic aryl, monocarbocyclic aryl lower alkyl, monocyclic heterocyclic or mono Cyclic heterocyclic lower alkyl group, R 2 is lower alkyl, halo alkyl, carboxy lower alkyl, monocyclic cycloalkyl, monocarbocyclic aryl, mono carbocyclic aryl lower alkyl, monocyclic heterocyclic or mono Cyclic heterocyclic lower alkyl group.
제4항에 있어서, R1및 R2가 모두 메틸기인 방법.The method of claim 4, wherein R 1 and R 2 are both methyl groups. 제4항에 있어서 공정 (a)에서는 6당량 이하의 에피클로로히드린을 사용하고 반응을 유기 용매 부재하에서 진행하며, 공정 (b)에서는 5당량의 tert-부틸아민을 사용하고 반응을 유기 용매 부재하에서 진행하는 방법The process according to claim 4, wherein in step (a) no more than 6 equivalents of epichlorohydrin are used and the reaction is carried out in the absence of an organic solvent, in step (b), 5 equivalents of tert-butylamine are used and the reaction is carried out in the absence of an organic solvent. How to proceed under
KR8204038A 1982-09-07 1982-09-07 Process for preparing 2,3-cis 1,2,3,4-tetrahydro-5-(2-hydroxy-3-tert-butylamino)propoxy-2,3-napththalenediol KR890001809B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR8204038A KR890001809B1 (en) 1982-09-07 1982-09-07 Process for preparing 2,3-cis 1,2,3,4-tetrahydro-5-(2-hydroxy-3-tert-butylamino)propoxy-2,3-napththalenediol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR8204038A KR890001809B1 (en) 1982-09-07 1982-09-07 Process for preparing 2,3-cis 1,2,3,4-tetrahydro-5-(2-hydroxy-3-tert-butylamino)propoxy-2,3-napththalenediol

Publications (2)

Publication Number Publication Date
KR840001567A KR840001567A (en) 1984-05-07
KR890001809B1 true KR890001809B1 (en) 1989-05-23

Family

ID=19225537

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8204038A KR890001809B1 (en) 1982-09-07 1982-09-07 Process for preparing 2,3-cis 1,2,3,4-tetrahydro-5-(2-hydroxy-3-tert-butylamino)propoxy-2,3-napththalenediol

Country Status (1)

Country Link
KR (1) KR890001809B1 (en)

Also Published As

Publication number Publication date
KR840001567A (en) 1984-05-07

Similar Documents

Publication Publication Date Title
KR960016119B1 (en) Imidazolidines substituted by a hydroxymethyl and a substituted phenyl radical, process for their preparation, their use as medicines, pharmaceutical compositions containing them and an intermediate for their preparation
JPS6141917B2 (en)
KR19980019751A (en) Method for preparing 3-amino-1-hydroxypropane-1,1-diphosphonic acid
US10053420B2 (en) Processes for the preparation of compounds, such as 3-arylbutanals, useful in the synthesis of medetomidine
BG64701B1 (en) Method for the preparation of 2-azadihydroxybicyclo[2.2.1]heptane compound and a salt of the compound and l-tartaric acid
KR890001809B1 (en) Process for preparing 2,3-cis 1,2,3,4-tetrahydro-5-(2-hydroxy-3-tert-butylamino)propoxy-2,3-napththalenediol
EP0165636B1 (en) Process for preparing azetidine derivatives and intermediates therein
CA1152087A (en) Aryl-substituted furanes, and process for their production
JPS6319499B2 (en)
Field et al. Synthesis of. alpha.-dehydrobiotin
Pelletier et al. The pyrodelphonine chromophore. Crystal structures of pyrodelphinine and delphinine
Barluenga et al. Regiospecific synthesis of isoxazoles by reaction of 1-azabutadiene derivatives with hydroxylamine hydrochloride
KR960005955B1 (en) Benzo£b|thiophen-5-yl derivatives and the process for producing the same
CA2217171C (en) New process for preparing (-)-trans-n-p-fluorobenzoylmethyl-4-(p-fluorophenyl)-3-¢¢3,4-(methylenedioxy)phenoxy!methyl!-piperidine
HU200448B (en) Process for production of 1-alkyl-5-nitro-imidasoles
KR790001648B1 (en) Process for the preparation of trimethoxy benzyl piperazino ethanol deriyatives
US3655655A (en) Process of preparing 5-benzyl-3-furanmethanol and intermediates therefor
KR100449317B1 (en) Process for the preparation of arbutin derivatives
CH655716A5 (en) CHIRAL CYCLOPENTENE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION.
HU186574B (en) Process for producing 2,3-cys-1,2,3,4-tetrahydro-5-/2-hidroxy-3-terc-butylamino/-propoxy/-2,3-naphtalene-diol
EP0339564B1 (en) Carbamate derivatives and a process for their production
EP0781270B1 (en) Ring-opening amidation process
KR950013147B1 (en) Process for preparing dioxorane derivatives
JPH0148267B2 (en)
KR800001281B1 (en) Process for the production of substituted arylal-kylamines